Health-care companies ticked up as traders hedged their bets on the outlook for growth in the sector.

The Federal Trade Commission said Friday it had agreed to end its legal challenge of drugmaker Amgen's $27.8 billion deal to buy Horizon Therapeutics, averting a trial that was to have started this month.

Kewaunee Scientific shares rose after the company reported first-quarter earnings, after a loss in the same quarter last year.

Rosalind Brewer stepped down as chief executive of Walgreens Boots Alliance less than three years after assuming leadership of the pharmacy chain.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

09-01-23 1711ET